Kilian Kelly

Kilian Kelly

Chief Executive Officer at CYNATA THERAPEUTICS LIMITED

Net worth: 65 142 $ as of 30/03/2024

Commercial Services
Health Technology
Consumer Services

Profile

Kilian Kelly is currently the Chief Executive Officer & Managing Director at Cynata Therapeutics Ltd.
He is also a Member of the Regulatory Affairs Professionals Society, the Royal Pharmaceutical Society of Great Britain, the International Society for Cellular Therapy, the Australian Institute of Co. Directors, and The Organisation for Professionals in Regulatory Affairs Ltd.
In the past, Dr. Kelly held the position of Senior Director-Drug Development at Aviragen Therapeutics, Inc. and Vice President-Regulatory & Clinical at Mesoblast Ltd.
Dr. Kelly obtained a doctorate degree from the University of Strathclyde and a graduate degree from The Robert Gordon University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
29/06/2023 525,508 ( 0.29% ) 65 142 $ 30/03/2024

Kilian Kelly active positions

CompaniesPositionStart
CYNATA THERAPEUTICS LIMITED Chief Executive Officer 30/06/2023
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
All active positions of Kilian Kelly

Former positions of Kilian Kelly

CompaniesPositionEnd
MESOBLAST LIMITED Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
See the detail of Kilian Kelly's experience

Training of Kilian Kelly

University of Strathclyde Doctorate Degree
The Robert Gordon University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kilian Kelly's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MESOBLAST LIMITED

Health Technology

CYNATA THERAPEUTICS LIMITED

Health Technology

Private companies6

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

See company connections